Form 4: Precigen CEO Sells Shares for Tax Withholding

Precigen's President and CEO, Helen Sabzevari, sold 119,250 shares of common stock to cover tax obligations upon the vesting of restricted stock units.

Summary

• Helen Sabzevari, President and CEO of Precigen, Inc., reported a transaction on May 28, 2026.
• The transaction involved the sale of 119,250 shares of Precigen common stock.
• This sale was a 'sell-to-cover' transaction to satisfy tax withholding obligations.
• The tax obligations arose from the vesting of restricted stock units on May 23, 2026.
• The sale price was $4.36 per share.
• Following this transaction, Sabzevari beneficially owns 3,768,872 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard procedural sale for tax purposes rather than an indication of the executive's view on the company's future prospects.

Negatives

• The CEO sold a significant number of shares, although it was for tax withholding purposes.

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions, often related to executive compensation plans like restricted stock units. The 'sell-to-cover' mechanism is a standard method for executives to manage tax liabilities without needing to raise external capital.

Stakeholder Impact

• Shareholders: The sale is a routine tax event for the CEO and does not inherently signal a change in the CEO's long-term conviction in the company, though a large sale can sometimes be perceived negatively in the short term.
• Employees: This transaction is related to executive compensation and does not directly impact other employees.
• Creditors: No direct impact on creditors is indicated by this filing.

Key Dates

Keywords

Precigen, PGEN, Form 4, insider trading, stock sale, tax withholding, restricted stock units, executive compensation